Month: October 2022

On October 31, 2020, Ghotbi, Golaleh; Mahdavi, Mohammad; Najafi, Zahra; Moghadam, Farshad Homayouni; Hamzeh-Mivehroud, Maryam; Davaran, Soodabeh; Dastmalchi, Siavoush published an article.COA of Formula: C9H8N2S The title of the article was Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer’s disease. And the article contained the following:

New compounds containing thiazole and pyridinium moieties were designed and synthesized. The potency of the synthesized compounds as selective inhibitors of acetylcholinesterase (AChE), and β-amyloid aggregation (Aβ) was evaluated. Compounds 7d and 7j showed the best AChE inhibitory activities at the submicromolar concentration range (IC50 values of 0.40 and 0.69μM, resp.). Most of the novel compounds showed moderate to low inhibition of butyrylcholinesterase (BChE), which is indicative of their selective inhibitory effects towards AChE. Kinetic studies using the most potent compounds 7d and 7j confirmed a mixed-type of AChE inhibition mechanism in accordance with the docking results, which shows their interactions with both catalytic active (CAS) and peripheral anionic (PAS) sites. The specific binding of 7a, 7j, and 7m to PAS domain of AChE was also confirmed exptl. In addition, 7d and 7j were able to show β-amyloid self-aggregation inhibitory effects (20.38 and 42.66% resp.) stronger than donepezil (14.70%) assayed at 10μM concentration Moreover, compounds 7j and 7m were shown to be effective neuroprotective agents in H2O2-induced oxidative stress on PC12 cells almost similar to those observed for donepezil. The ability of 7j to pass blood-brain barrier was demonstrated using the PAMPA method. The results presented in this work provide useful information about designing novel anti-Alzheimer agents. The experimental process involved the reaction of 4-Phenylthiazol-2-amine(cas: 2010-06-2).COA of Formula: C9H8N2S

The Article related to thiazole pyridinium derivative preparation ache amyloid aggregation inhibitor alzheimer’s, acetylcholinesterase, alzheimer’s disease, docking study, neuroprotection, thiazole-pyridinium, β-amyloid self-aggregation and other aspects.COA of Formula: C9H8N2S

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On April 16, 2022, Chen, Xuefeng; Lu, Yalong; Zhao, Aiqing; Wu, Yingmei; Zhang, Yuanyuan; Yang, Xingbin published an article.Formula: C5H5NOS The title of the article was Quantitative analyses for several nutrients and volatile components during fermentation of soybean by Bacillus subtilis natto. And the article contained the following:

This study is to reveal the variation of five pivotal substances, including polysaccharides, proteins, isoflavones, fatty acids and volatile components during the soybean fermentation process by Bacillus subtilis natto. After 96 h of soybean fermentation, the polysaccharide contents were significantly decreased, and the glucose and galactose contents showed the greatest decline in all the monosaccharide components. Moreover, isoflavone glycoside levels were decreased, while the isoflavone aglycon levels were increased following the fermentation In addition, the SCFAs contents were also significantly increased in comparison with the unfermented soybean. Furthermore, 16 amino acids and 36 volatile components were detected in the fermented soybean. Finally, 21 key compounds were identified through PCA and OPLS-DA anal. of total compounds in the fermentation process. These findings demonstrated that Bacillus subtilis natto had a significant influence on the biochem. profiles of soybean fermentation and consequently contributed to its unique quality. The experimental process involved the reaction of 2-Acetylthiazole(cas: 24295-03-2).Formula: C5H5NOS

The Article related to bacillus soybean glucose galactose isobutyric acid phenylalanine histidine fermentation, bacillus subtilis natto, fermentation stage, isoflavones, short chain fatty acids, soybean fermentation, volatile components and other aspects.Formula: C5H5NOS

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On March 31, 2008, Rao, V. Rajeswar; Reddy, V. Ravinder published an article.HPLC of Formula: 64987-16-2 The title of the article was Synthesis of some new types of 3-coumarinyl-substituted pyrazolopyrimidines and imidazothiazoles. And the article contained the following:

The treatment of 3-[3-(dimethylamino)-1-oxo-2-propenyl]chromen-2-ones with 3-amino-4-cyanopyrazole gave 7-(2-oxo-2H-chromen-3-yl)pyrazolo[1,5-a]pyrimidine-3-carbonitriles. The reaction of 3-(2-bromoacetyl)coumarins with 2-amino-4-(methoxycarbonylmethyl)thiazole and 2-amino-4-methylthiazole gives Me 2-(6-(2-oxo-2H-chromen-3-yl)imidazo[2,1-b]thiazol-3-yl)acetate and 3-(2-methylimidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-ones, resp. The experimental process involved the reaction of Methyl 2-(2-aminothiazol-4-yl)acetate(cas: 64987-16-2).HPLC of Formula: 64987-16-2

The Article related to aminopropenonyl chromenone cyclocondensation aminocyanopyrazole, bromoacetyl chromenone cyclocondensation aminothiazole, coumarinyl pyrazolopyrimidine preparation imidazothiazole, imidazothiazole coumarinyl preparation and other aspects.HPLC of Formula: 64987-16-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On October 15, 2020, Mourad, Ahmed A. E.; Mourad, Mai A. E. published an article.Category: thiazole The title of the article was Enhancing insulin sensitivity by dual PPARγ partial agonist, β-catenin inhibitor: Design, synthesis of new α-phthalimido-o-toluoyl-2-aminothiazole hybrids. And the article contained the following:

We aimed at synthesizing novel partial PPARγ agonists with β-catenin inhibitory activity which was enhanced insulin sensitivity and avoid the side effects of full PPARγ agonists. We synthesized novel series of α-phthlimido-o-toluoyl-2-aminothiazoles I [R1=R2=R3=R4 = H; R2 = H, Me, MeO, Cl, etc.] hybrids for evaluating their antidiabetic activity and discovering its mechanistic pathway. We assessed effect of the new hybrids I on PPARγ activation using a luciferase reporter assay system. Moreover, intracellular triglyceride levels, gene levels of c/EBPα, PPARγ and PPARγ targets including GLUT4, adiponectin, aP2 were measured in 3T3-L1 cells. Uptake of 2-DOG together with PPARγ and β-catenin protein levels were evaluated in 3T3-L1cells. In addition, mol. docking studies with PPARγ LBD, physicochem. properties and structure activity relationship of the novel hybrids I were also studied. Three of the synthesized hybrids I showed partial PPARγ agonistic activity and distinct PPARγ binding pattern. These compounds I modulated PPARγ gene expression and PPARγ target genes; and increased glucose uptake in 3T3-L1 and slightly induced adipogenesis compared to rosiglitazone. Moreover, these compounds I reduced β-catenin protein level which reflected in increased both PPARγ gene and protein levels that leads to improved insulin sensitivity and increased GLUT4 and adiponectin gene expression. This synthesized compounds act as novel partial PPARγ agonists and β-catenin inhibitors that have potent insulin sensitizing activity and mitigate the lipogenic side effects of TZDs. The experimental process involved the reaction of 4-Phenylthiazol-2-amine(cas: 2010-06-2).Category: thiazole

The Article related to dioxoisoindolinylmethyl phenylthiazolyl benzamide preparation peroxisome proliferator activated receptor agonist, 2-aminothiazole, partial pparγ agonist, thiazolidinediones, wnt/β-catenin inhibitor, α-phthlimido-o-toluoyl and other aspects.Category: thiazole

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On February 15, 2007, Nunes, Joseph J.; Milne, Jill; Bemis, Jean; Xie, Roger; Vu, Chi B.; Ng, Pui Yee; Disch, Jeremy S.; Salzmann, Thomas; Armistead, David published a patent.Computed Properties of 64987-16-2 The title of the patent was Preparation of benzothiazoles and thiazolopyridines as sirtuin modulators. And the patent contained the following:

The title compounds I [X7-X10 = N, CR20 or CR11 (wherein R20 = H or solubilizing group; R11 = H, (un)substituted alkyl); R19 = phenylene, pyridylene, etc.; R21 = (un)substituted NHCO, NHSO2, NHCONH, etc.; R31 = (un)substituted monocyclic or bicyclic (hetero)aryl; with proviso] and their analogs which are novel sirtuin-modulating compounds useful for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity, were prepared E.g., a multi-step synthesis of II, starting from 4-aminopyridin-3-yl diisopropylcarbamodithioate and 3-nitrobenzoyl chloride, was given. Exemplified compounds I were tested for sirtuin modulating activity (data given). Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent. The experimental process involved the reaction of Methyl 2-(2-aminothiazol-4-yl)acetate(cas: 64987-16-2).Computed Properties of 64987-16-2

The Article related to benzimidazole preparation sirtuin modulator antidiabetic antiobesity cardiovascular antiinflammatory antitumor, benzothiazole preparation sirtuin modulator antidiabetic antiobesity cardiovascular antiinflammatory antitumor and other aspects.Computed Properties of 64987-16-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

Cernosek, Terezie; Eckert, Kevin E.; Carter, David O.; Perrault, Katelynn A. published an article in 2020, the title of the article was Volatile Organic Compound Profiling from Postmortem Microbes using Gas Chromatography-Mass Spectrometry.Recommanded Product: 24295-03-2 And the article contains the following content:

Volatile organic compounds (VOCs) are byproducts of cadaveric decomposition and are responsible for the odor associated with decomposing remains. The direct link between VOC production and individual postmortem microbes has not been well characterized exptl. The purpose of this study was to profile VOCs released from three postmortem bacterial isolates (Bacillus subtilis, Ignatzschineria indica, I. ureiclastica) using solid-phase microextraction arrow (SPME Arrow) and gas chromatog.-mass spectrometry (GC-MS). Species were inoculated in headspace vials on Standard Nutrient Agar and monitored over 5 days at 24°C. Each species exhibited a different VOC profile that included common decomposition VOCs. VOCs exhibited upward or downward temporal trends over time. Ignatzschineria indica produced a large amount of dimethyldisulfide. Other compounds of interest included alcs., aldehydes, aromatics, and ketones. This provides foundational data to link decomposition odor with specific postmortem microbes to improve understanding of underlying mechanisms for decomposition VOC production The experimental process involved the reaction of 2-Acetylthiazole(cas: 24295-03-2).Recommanded Product: 24295-03-2

The Article related to forensic volatile organic compound gas chromatog mass spectrometry, cadaver decomposition, decomposition odor, forensic chemistry, forensic science, forensic taphonomy, postmortem microbiology, solid-phase microextraction arrow and other aspects.Recommanded Product: 24295-03-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On October 20, 2021, Marcinkowska, Monika; Frank, Stephanie; Steinhaus, Martin; Jelen, Henryk H. published an article.HPLC of Formula: 24295-03-2 The title of the article was Key Odorants of Raw and Cooked Green Kohlrabi (Brassica oleracea var. gongylodes L.). And the article contained the following:

Volatile compounds of raw and cooked green kohlrabi were investigated using a sensomics approach. A total of 55 odor-active compounds were detected and identified in raw and cooked green kohlrabi using GC-O. Twenty-eight odor-active compounds with high flavor dilution (FD) factors ranging from 64 to 1024 were quantitated, and odor activity values (OAVs) were determined Eight compounds showed high OAVs in raw and cooked kohlrabi: five sulfur compounds (di-Me trisulfide, Me 2-methyl-3-furyl disulfide, and three isothiocyanates (1-isothiocyanato-3-(methylsulfanyl)propane, benzyl isothiocyanate, and 1-isothiocyanato-4-(methylsulfanyl)butane)), two lipid oxidation products (1-octen-3-one and trans-4,5-epoxy-(2E)-dec-2-enal), and 2-isopropyl-3-methoxypyrazine. Among these, the sulfur compounds contributed most to the overall smell of the raw and cooked vegetables. The quantitation anal. indicates that the eight odorants are the backbone compounds for raw and cooked kohlrabi. The OAVs for the backbone compounds and also for minor odorants are clearly higher in raw kohlrabi than in the cooked one. Differences can be explained by the influence of the cooking process. The experimental process involved the reaction of 2-Acetylthiazole(cas: 24295-03-2).HPLC of Formula: 24295-03-2

The Article related to odorant raw cooked brassica kohlrabi, gc-o, aroma extract dilution analysis (aeda), isothiocyanate (itc), kohlrabi (brassica oleracea var. gongylodes l.), nitrile, odor activity value (oav), stable isotope dilution assay (sida) and other aspects.HPLC of Formula: 24295-03-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On July 1, 2019, Olawode, Emmanuel O.; Tandlich, Roman; Prinsloo, Earl; Isaacs, Michelle; Hoppe, Heinrich; Seldon, Ronnett; Warner, Digby F.; Steenkamp, Vanessa; Kaye, Perry T. published an article.Computed Properties of 2010-06-2 The title of the article was Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones. And the article contained the following:

A series of novel, substituted 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones have been prepared and shown to exhibit promising concentration-dependent activity against human SH-SY5Y cells, Plasmodium falciparum, Mycobacterium tuberculosis and P. aeruginosa. Substituent effects on observed bioactivity have been explored; the para-fluorophenyl derivative I exhibited activity across the range of the bioassays employed, indicating the potential of the 2-chloro-3-[(4-arylthiazol-2-yl)amino]-1,4-naphthoquinone scaffold in the development of novel, broad spectrum therapeutics. The experimental process involved the reaction of 4-Phenylthiazol-2-amine(cas: 2010-06-2).Computed Properties of 2010-06-2

The Article related to chlorothiazolylaminonaphthoquinone preparation antimalaria antibacterial antituberculosis anticancer, 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones, anti-bacterial, anti-malarial, anti-tuberculosis, cytotoxicity, hela cells and other aspects.Computed Properties of 2010-06-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On January 1, 2017, Tomasic, Tihomir; Mirt, Matic; Barancokova, Michaela; Ilas, Janez; Zidar, Nace; Tammela, Paivi; Kikelj, Danijel published an article.SDS of cas: 64987-16-2 The title of the article was Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide derivatives as novel DNA gyrase inhibitors. And the article contained the following:

Two new series of Escherichia coli DNA gyrase inhibitors bearing the 4,5-dibromopyrrolamide moiety was designed and synthesized. 4,5,6,7-Tetrahydrobenzo[1,2-d]thiazole-2,6-diamine derivatives inhibited E. coli DNA gyrase in the submicromolar to low micromolar range (IC50 values between 0.891 and 10.4 μM). Their “ring-opened” analogs, based on the 2-(2-aminothiazol-4-yl)acetic acid scaffold, displayed weaker DNA gyrase inhibition with IC50 values between 15.9 and 169 μM. Mol. docking experiments were conducted to study the binding modes of inhibitors. The experimental process involved the reaction of Methyl 2-(2-aminothiazol-4-yl)acetate(cas: 64987-16-2).SDS of cas: 64987-16-2

The Article related to amido tetrahydrobenzothiazolyl pyrrolylcarboxamide preparation sar dna gyrase mol docking, phenyl acetamidothiazolyl pyrrolylcarboxamide preparation sar dna gyrase mol docking, antibacterial, dna gyrase, docking, inhibitor, thiazole and other aspects.SDS of cas: 64987-16-2

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica

On July 17, 2008, Murray, Anthony; Lau, Jesper; Vedsoe, Per; Christiansen, Lise Brown published a patent.Application of 859522-19-3 The title of the patent was Preparation of ureidothiazolylthioalkanoates as glucokinase activators. And the patent contained the following:

Title compounds were prepared for treatment of diabetes, impaired glucose tolerance, obesity, hyperglycemia, syndrome X, and dyslipidemia (no data). Thus, [2-(2-chlorobenzyloxy)ethyl]-(trans-4-methylcyclohexyl)amine TFA salt (preparation given), Et 3-(2-aminothiazol-5-ylthio)-2,2-dimethylpropionate (preparation given), carbonyldiimidazole, and DMAP were stirred together in THF for 18 h; EtOH and aqueous NaOH were added followed by heating at 75° for 5 h to give 53% 3-[2-[3-[2-(2-chlorobenzyloxy)ethyl]-3-(trans-4-methylcyclohexyl)ureido]thiazol-5-ylthio]-2,2-dimethylpropionic acid. The experimental process involved the reaction of Ethyl 2-((2-aminothiazol-5-yl)thio)acetate(cas: 859522-19-3).Application of 859522-19-3

The Article related to ureidothiazolylthioalkanoate preparation glucokinase activator, diabetes obesity hyperglycemia syndrome x treatment thiazolylthioalkanoate ureido preparation, methylcyclohexylureidothiazolylsulfanylalkanoate preparation antidiabetic and other aspects.Application of 859522-19-3

Referemce:
Thiazole | C3H3NS – PubChem,
Thiazole | chemical compound | Britannica